Lexology July 26, 2022
DLA Piper

Telemedicine companies, beware: on July 20, 2022, the United States Department of Health and Human Services, Office of Inspector General (OIG) issued a new Special Fraud Alert targeting arrangements between practitioners and purported telemedicine companies, signaling a heightened focus by the government on fraud in the telemedicine industry.

While OIG drafted the alert broadly to apply to telehealth, telemedicine, and telemarketing services (collectively referred to in the Alert as Telemedicine Companies), the agency highlighted arrangements whereby practitioners order or prescribe a federally reimbursable item and/or service for patients they never examine or meaningfully assesses to determine whether such item is or service is medically necessary. OIG remarked that these arrangements commonly involve Telemedicine Companies paying practitioners on a per-click basis...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Health IT, HHS, OIG, Provider, Technology, Telehealth
Venture-backed telemental health care companies are creating a new opioid epidemic
Increased Skilled Nursing Facility Spending Tied to Health Systems’ Higher Telemedicine Use
Telehealth linked to modest quality, cost increases, study finds
Audio-only telehealth boosts heart failure care for Native Americans
What Does the FTC’s $7M Fine Against Cerebral Mean for the Industry?

Share This Article